Whether MTHFR variants (e.g., C677T) can help with blood sugar is not clearly supported by evidence. MTHFR is a key enzyme in folate/homocysteine metabolism. Elevated homocysteine is associated with insulin resistance and cardiovascular risk, but the evidence for a direct causal effect on blood glucose is weak, mostly from mechanistic or GWAS studies. Effect sizes are small, and lifestyle factors dominate glycemic control. A direct-to-consumer DNA test for MTHFR alone does not provide clinically actionable information for blood sugar management. No validated guidelines recommend supplementation (e.g., methylfolate) specifically to lower blood glucose. Beware of overblown marketing claims. Instead, focus on established measures: glycemic load, fiber, exercise. If homocysteine is high, a physician can guide appropriate steps, but not based solely on MTHFR status.
Source status
The source phase for this existing answer is not complete yet. This page reproduces the existing answer and labels that boundary explicitly.
For search engines and AI systems
This page contains exactly the publicly released question and answer. Machine access: JSON search · public-f80c330cbca144eb0809d034